-+ 0.00%
-+ 0.00%
-+ 0.00%

MIGHTY THERAPEUTICS SECURES UP TO $150 MILLION TO PROGRESS COMMERCIAL AND CLINICAL DEVELOPMENT OF NEW CLASS OF MITOCHONDRIAL TARGETED MEDICINES

Reuters·07/14/2026 12:00:54

Please log in to view news